Medical Information Technology Inc (MITII) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MITII Annual Balance Sheets →
From Medical Information Technology Inc through Sep 30 2019, shifts in Sep 30 2020's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2020)
(Jun 30 2020) (Mar 31 2020) (Dec 31 2019) (Sep 30 2019)
Assets
Cash & cash equivalent50.13
Marketable Securities372.47
Cash & Short-term Investments422.00
Accounts receivable44.45
Other Current Assets11.73
Total Current Assets478.78
Equipment/Property/Plant Net161.65
Tax Assets, Noncurrent7.59
Other Assets, Noncurrent7.11
Total Assets655.13
Liabilities
Accounts Payable0.37
Accrued Liabilities, Current30.86
Other Liabilities, Current0.00
Taxes Payable1.49
Deferred Liability and Revenue51.26
Total Current Liabilities83.98
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent17.60
Other liabilities, Noncurrent16.05
Total Liabilities117.63
Stockholders' Equity
Common Stock Value37.19
Additional Paid In Capital Common Stock122.91
Retained Earnings / Accumulated Deficit377.41
Other Equity0.00
Common Stockholder's Equity537.50
Total Stockholder's Equity537.50
Liabilities & Stockholder's Equity655.13
4 historic quarters locked

Sign in to unlock the full Medical Information Technology Inc balance sheet history.

About MITII Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.